Filter
5708
Filtered Results: 5708
Text search:
burden
of
disease
Featured
Recommendations
463
New Publications
1380
Language
Document type
No document type
3004
Studies & Reports
1291
Guidelines
624
Strategic & Response Plan
253
Manuals
233
Fact sheets
138
Training Material
69
Situation Updates
28
Infographics
25
Resource Platforms
23
Brochures
7
Dashboards/Maps
5
Online Courses
5
Videos
3
Countries / Regions
Global
361
India
259
Kenya
178
Western and Central Europe
143
South Africa
138
Ethiopia
117
Africa
110
Latin America and the Carribbean
103
Uganda
97
Nigeria
94
Sierra Leone
90
Liberia
85
Tanzania
81
Nepal
78
Malawi
78
Zambia
72
Bangladesh
68
Ghana
67
Rwanda
61
Ukraine
61
Eastern Europe
60
Namibia
54
Myanmar / Burma
53
Syria
49
South–East Asia Region
49
Asia
49
Philippines
41
Mozambique
39
Zimbabwe
34
East and Southern Africa
34
Cambodia
33
Congo, Democratic Republic of
32
Russia
32
South Sudan
31
Lesotho
31
Indonesia
30
West and Central Africa
29
Brazil
28
Guinea
23
Botswana
23
Eastern Europe and Central Asia
22
Senegal
20
Germany
20
Middle East and North Africa
20
Pakistan
19
Eswatini/ Swaziland
17
Haiti
16
Burkina Faso
15
Sudan
15
Cameroon
14
Yemen
14
North America
14
Colombia
13
Western Pacific Region
13
USA
12
Venezuela
12
Afghanistan
11
Somalia
10
Thailand
10
Vietnam
10
Jordan
8
Benin
8
Central African Republic
8
Albania
8
Tajikistan
8
Iraq
7
Argentina
7
Peru
7
Chile
7
Moldova
7
Mali
6
Lebanon
6
Ecuador
6
Madagascar
6
Sri Lanka
6
Southern Africa
6
Laos
6
Georgia
6
North Macedonia
5
Mexico
5
Paraguay
5
Palestine
5
Iran
5
Jamaica
5
Saudi Arabia
4
Turkey
4
Egypt
4
China
4
Burundi
4
Libya
4
Angola
4
Armenia
4
Timor Leste/ East Timor
4
Greece
3
Poland
3
Romania
3
Kyrgyzstan
3
Turkmenistan
3
Mauritius
3
United Kingdom
3
Belarus
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Switzerland
2
Other region
2
Bhutan
2
Djibouti
2
Qatar
2
Kazakhstan
2
Gabon
2
Tunisia
2
Bosnia and Herzegovina
2
Morocco
1
Niger
1
Togo
1
Chad
1
Gambia
1
Ireland
1
Hungary
1
Honduras
1
El Salvador
1
Bolivia
1
Guatemala
1
North Korea
1
Mongolia
1
Canada
1
Bulgaria
1
Estonia
1
Slovakia
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Morocco
1
Azerbaijan
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
2043
Clinical Guidelines
531
Public Health
498
Women & Child Health
209
Key Resources
173
Capacity Building
66
Pharmacy & Technologies
37
Annual Report MEDBOX
2
Toolboxes
TB
503
HIV
484
Mental Health
460
COVID-19
414
NCDs
295
Planetary Health
265
AMR
217
NTDs
213
Disability
141
Global Health Education
133
Caregiver
130
Rapid Response
119
Conflict
111
Ebola
80
Health Financing Toolbox
76
Refugee
71
Pharmacy
58
Natural Hazards
41
Polio
29
Cholera
28
Zika
18
Social Ethics
18
Specific Hazards
15
South Sudan
1
Health Financing
1
In 2009, WHO’s Second International Conference on Buruli Ulcer Control and Research resolved to strengthen the capacity of national laboratories to confirm cases of the ..., but advised that “efforts are still needed to develop simple diagnostic tools usable in the field as well as disability prevention methods”.
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive predictive value to put patients on appropriate treatment; and
a screening test at the primary health care or community level for symptomatic patients with ulcer
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection ... Buruli ulcer in symptomatic patients with sufficient positive predictive value to put patients on appropriate treatment; and
a screening test at the primary health care or community level for symptomatic patients with ulcer
In March 2018, they convened a global meeting with the aim of establishing an action plan to develop new diagnostic solutions for Buruli ulcer and to create a framework of collaboration to address unmet needs in diagnostics for the disease. The participants agreed to develop a target product profile (TPP) to address the need for a rapid diagnostic test for use at the primary health-care level.
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most e...
To assess the impact of the COVID-19 pandemic on health and HIV expenditure, UNAIDS carried out a modelling study on fiscal space for health and HIV. From a sample of 28 countries, three countries...
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respon...
Aerosol pollutants are known to raise the risk of development of non-communicable respiratory diseases (NCRDs) such as asthma, chronic bronchitis, ...
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation ... contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 infection. In the context of growing global population immunity from COVID-19 vaccination and past SARS-CoV-2 infection, WHO recommends that identification, contact, quarantine and follow-up should be prioritized for individuals at high risk who have been in contact with a confirmed or probable case of SARS-CoV-2 infection, rather than targeting all contacts. This updated guidance also introduces shorter recommended quarantine periods, including the ability to further shorten quarantine through the use of testing. National and local health authorities should use risk-based approaches to contact tracing and quarantine that include reviewing and adjusting to their local circumstances and disease epidemiology, population immunity, their health system’s capacities, and risk tolerance.
There is growing understanding and high-level endorsement of the importance of strong collaborative multisectoral approaches to address a broad range of...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and ... NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply, including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. An analysis of different eradication strategies is included, as well as of the role of women in the cocaine supply chain. The chapter also presents the latest estimates of and trends in cocaine use, including a brief introduction to the various cocaine consumer products. Finally, it reviews the trends in the use of cocaine and the impact of the coronavirus disease (COVID-19) pandemic in different regions
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of pub...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one ... the most serious public health burdens among the most deprived communities, have only recently drawn the attention of major donors. While frequently stated, the low share
of funding for NTD control projects has not been calculated empirically. Our analysis of ODA commitments for infectious disease control for the years 2003 to 2007 confirms that Development Assistance Committee (DAC)-countries and multilateral donors have largely ignored funding NTD control projects. On average, only 0.6% of total annual health ODA was dedicated
to the fight against NTDs while the average share of control projects for HIV/AIDS was 36.3%, for malaria 3.6%, and for tuberculosis 2.2%. This allocation of health ODA does not reflect the diseases’ respective health burdens.
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such a...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association ...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AM...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management ... cutaneous leishmaniasis. With this manual, countries will have, for the first time, standardized diagnosis and treatment protocols, case definitions and indicators to enable them to easily track progress on cutaneous leishmaniasis case management across the Region. It will provide support to professionals in charge of cutaneous leishmaniasis, in order to alleviate the suffering of affected populations from this appalling disfiguring and stigmatizing neglected tropical disease.
In October 2022, President Biden signed the Global Malnutrition Prevention and Treatment Act (GMPTA) into law, which directs USAID to prevent and treat malnutrition globally. The GMPTA further codifies USAID’s leadership on nutrition, with a focus on evidence-based interventions across health syst...
Antimicrobial resistance (AMR) is an increasing worldwide public health problem with
important implications for the European Union (EU). When antibiotics become
ineffective, bacterial infections lead to increased morbidity, use of healthcare,
mor...
